Characterizing and classifying neuroendocrine neoplasms through microRNA sequencing and data mining.
Journal
NAR cancer
ISSN: 2632-8674
Titre abrégé: NAR Cancer
Pays: England
ID NLM: 101769553
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
06
03
2020
revised:
22
05
2020
accepted:
06
06
2020
entrez:
4
8
2020
pubmed:
4
8
2020
medline:
4
8
2020
Statut:
ppublish
Résumé
Neuroendocrine neoplasms (NENs) are clinically diverse and incompletely characterized cancers that are challenging to classify. MicroRNAs (miRNAs) are small regulatory RNAs that can be used to classify cancers. Recently, a morphology-based classification framework for evaluating NENs from different anatomical sites was proposed by experts, with the requirement of improved molecular data integration. Here, we compiled 378 miRNA expression profiles to examine NEN classification through comprehensive miRNA profiling and data mining. Following data preprocessing, our final study cohort included 221 NEN and 114 non-NEN samples, representing 15 NEN pathological types and 5 site-matched non-NEN control groups. Unsupervised hierarchical clustering of miRNA expression profiles clearly separated NENs from non-NENs. Comparative analyses showed that miR-375 and miR-7 expression is substantially higher in NEN cases than non-NEN controls. Correlation analyses showed that NENs from diverse anatomical sites have convergent miRNA expression programs, likely reflecting morphological and functional similarities. Using machine learning approaches, we identified 17 miRNAs to discriminate 15 NEN pathological types and subsequently constructed a multilayer classifier, correctly identifying 217 (98%) of 221 samples and overturning one histological diagnosis. Through our research, we have identified common and type-specific miRNA tissue markers and constructed an accurate miRNA-based classifier, advancing our understanding of NEN diversity.
Identifiants
pubmed: 32743554
doi: 10.1093/narcan/zcaa009
pii: zcaa009
pmc: PMC7380486
doi:
Banques de données
Dryad
['10.5061/dryad.fn2z34tqj']
Types de publication
Journal Article
Langues
eng
Pagination
zcaa009Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR001866
Pays : United States
Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of NAR Cancer.
Références
Cancer Cytopathol. 2016 Dec;124(12):871-884
pubmed: 27529763
Best Pract Res Clin Endocrinol Metab. 2016 Jan;30(1):59-77
pubmed: 26971844
Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5813-8
pubmed: 19289822
Arterioscler Thromb Vasc Biol. 2018 Jun;38(6):1321-1332
pubmed: 29724816
J Biol Chem. 2013 Apr 12;288(15):10361-73
pubmed: 23430746
PLoS Biol. 2007 Aug;5(8):e203
pubmed: 17676975
Clin Cancer Res. 2018 Dec 1;24(23):5873-5882
pubmed: 30061360
Am J Pathol. 2016 Apr;186(4):1025-35
pubmed: 26877261
Endocr Pathol. 2018 Jun;29(2):150-168
pubmed: 29520563
Mod Pathol. 2018 Aug;31(8):1302-1317
pubmed: 29487354
Endocr Relat Cancer. 2016 Sep;23(9):711-26
pubmed: 27353039
Endocr Relat Cancer. 2013 Oct 14;20(6):809-23
pubmed: 24127332
Endocr Relat Cancer. 2018 Mar;25(3):217-231
pubmed: 29298817
Mod Pathol. 2018 Dec;31(12):1770-1786
pubmed: 30140036
Nucleic Acids Res. 2016 May 5;44(8):3865-77
pubmed: 26921406
Oncotarget. 2017 Aug 9;8(41):70982-71001
pubmed: 29050337
Endocr Relat Cancer. 2019 Jan 1;26(1):47-57
pubmed: 30021866
EJIFCC. 2019 Jun 24;30(2):146-164
pubmed: 31263390
Methods. 2012 Oct;58(2):164-70
pubmed: 22885844
Gene Expr Patterns. 2009 Feb;9(2):109-13
pubmed: 18977315
J Am Soc Nephrol. 2017 Aug;28(8):2353-2363
pubmed: 28298326
Am J Clin Pathol. 2000 Mar;113(3):331-5
pubmed: 10705811
Adv Exp Med Biol. 2013;774:1-20
pubmed: 23377965
Crit Rev Oncol Hematol. 2017 May;113:268-282
pubmed: 28427516
Genes Dev. 2008 Apr 1;22(7):894-907
pubmed: 18381893
Endocrinology. 2015 Nov;156(11):3971-83
pubmed: 26322371
Cell. 2018 Mar 22;173(1):20-51
pubmed: 29570994
Nat Biotechnol. 2008 Apr;26(4):462-9
pubmed: 18362881
Endocr Pathol. 2016 Dec;27(4):284-311
pubmed: 27169712
Nature. 2005 Jun 9;435(7043):834-8
pubmed: 15944708
Cancer Res. 2016 Jul 1;76(13):3666-70
pubmed: 27325641
Cell. 2007 Jun 29;129(7):1401-14
pubmed: 17604727
Cell. 2009 Jan 23;136(2):215-33
pubmed: 19167326
Exp Mol Pathol. 2013 Aug;95(1):62-7
pubmed: 23685355
Methods. 2012 Oct;58(2):171-87
pubmed: 22836126
Visc Med. 2017 Oct;33(5):324-330
pubmed: 29177160
Virchows Arch. 2017 Nov;471(5):651-658
pubmed: 28861609
J Mol Med (Berl). 2015 Oct;93(10):1159-69
pubmed: 26013143
Genes Chromosomes Cancer. 2014 Oct;53(10):803-14
pubmed: 24898736
Front Genet. 2013 Aug 02;4:145
pubmed: 23935604
J Clin Invest. 2013 Jun;123(6):2694-702
pubmed: 23728175
Cancer Res. 2011 Oct 1;71(19):6165-73
pubmed: 21856745
Best Pract Res Clin Endocrinol Metab. 2016 Oct;30(5):563-575
pubmed: 27923451